Management of bronchiolitis in community hospitals in Ontario: A multicentre cohort study

Canadian Journal of Emergency Medicine

Volumn 18, Issue 6, 2016, Pages 443-452

  Plint, Amy C ^a   Taljaard, Monica ^a,b   McGahern, Candice ^b   Scott, Shannon D ^c   Grimshaw, Jeremy M ^a,b   Klassen, Terry P ^d   Johnson, David W ^e  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

^e UNIVERSITY OF CALGARY   (Canada)

Author keywords

Bronchiolitis; Children; Emergency department

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; EPINEPHRINE; IPRATROPIUM BROMIDE; SALBUTAMOL; BRONCHODILATING AGENT;

ARTICLE; BLOOD ANALYSIS; BRONCHIOLITIS; COHORT ANALYSIS; COMMUNITY HOSPITAL; FEMALE; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INFANT; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; MULTICENTER STUDY; NEBULIZER; RETROSPECTIVE STUDY; THORAX RADIOGRAPHY; UPPER RESPIRATORY TRACT INFECTION; URINALYSIS; WHEEZING; CLINICAL TRIAL; CLUSTER ANALYSIS; HOSPITAL ADMISSION; HOSPITAL EMERGENCY SERVICE; INCIDENCE; LENGTH OF STAY; OBSERVER VARIATION; ONTARIO; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; UTILIZATION;

ALBUTEROL; BRONCHIOLITIS; BRONCHODILATOR AGENTS; CLUSTER ANALYSIS; COHORT STUDIES; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITALS, COMMUNITY; HUMANS; INCIDENCE; INFANT; LENGTH OF STAY; MALE; OBSERVER VARIATION; ONTARIO; PATIENT ADMISSION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84992702503     PISSN: 14818035     EISSN: 14818043     Source Type: Journal    
DOI: 10.1017/cem.2016.7     Document Type: Article

References (41)

1. Njoo H, Pelletier L, Spika J. Infectious diseases. In Respiratory disease in Canada (eds. Canadian Institute for Health Information, Canadian Lung Association, Health Canada, and Statistics Canada). Ottawa: Canadian Institute for Health Information; 2001, 65-87.
2. Langley JM, LeBlanc JC, Smith B, et al. Increasing incidence of hospitalization for bronchiolitis among Canadian children, 1980-2000. J Infect Dis 2003;188(11):1764-7.
3. Craig E, Jackson C, Han DY, et al. Monitoring the Health of New Zealand Children and Young People: Indicator Handbook. Auckland, New Zealand: Paediatric Society of New Zealand, New Zealand Child and Youth Epidemiology Service; 2007.
4. Shay DK, Holman RC, Newman RD, et al. Bronchiolitisassociated hospitalizations among US children, 1980-1996. JAMA 1999;282(15):1440-6.
5. Mansbach JM, Pelletier AJ, Camargo CA. US outpatient office visits for bronchiolitis, 1993-2004. Ambul Pediatr 2007;7(4):304-7.
6. Mansbach JM, Emond JA, Camargo CA. Bronchiolitis in US emergency departments 1992 to 2000: epidemiology and practice variation. Pediatr Emerg Care 2005;21(4):242-7.
7. Vogel AM, Lennon DR, Harding JE, et al. Variations in bronchiolitis management between five New Zealand hospitals: can we do better? J Paediatr Child Health 2003; 39(1):40-5.
8. Plint AC, Johnson DW, Wiebe N, et al. Practice variation among pediatric emergency departments in the treatment of bronchiolitis. Acad Emerg Med 2004;11(4):353-60.
9. Schuh S, Lalani A, Allen U, et al. Evaluation of the utility of radiography in acute bronchiolitis. J Pediatr 2007; 150(4):429-33.
10. Todd J, Bertoch D, Dolan S. Use of a large national database for comparative evaluation of the effect of a bronchiolitis/viral pneumonia clinical care guideline on patient outcome and resource utilization. Arch Pediatr Adolesc Med 2002;156(11):1086-90.
11. Perlstein PH, Kotagal UR, Bolling C, et al. Evaluation of an evidence-based guideline for bronchiolitis. Pediatrics 1999;104(6):1334-41.
12. Adcock PM, Sanders CL, Marshall GS. Standardizing the care of bronchiolitis. Arch Pediatr Adolesc Med 1998; 152(8):739-44.
13. Kotagal UR, Robbins JM, Kini NM, et al. Impact of a bronchiolitis guideline: a multisite demonstration project. Chest 2002;121:1789-97.
14. Plint AC, Johnson DW, Patel H, et al. Epinephrine and dexamethasone in children with bronchiolitis. N Engl J Med 2009;360(20):2079-89.
15. Swingler GH, Hussey GD, Zwarenstein M. Duration of illness in ambulatory children diagnosed with bronchiolitis. Arch Pediatr Adolesc Med 2000;154(10):997-1000.
16. Donner A, Klar N. Confidence interval construction for effect measures arising from cluster randomization trials. J Clin Epidemiol 1993;46(2):123-31.
17. Donner A. A review of inference procedures for the intraclass correlation coefficient in the one-way random effects model. Int Stat Rev 1986;54:67-82.
18. Law BJ, De Carvalho V. Respiratory syncytial virus infections in hospitalized Canadian children: regional differences in patient populations and management practices. The Pediatric Investigators Collaborative Network on Infections in Canada. Pediatr Infect Dis J 1993;12(8):659-63.
19. Kellner JD, Ohlsson A, Gadomski AM, et al. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev 2000;2: CD001266.
20. Hartling L, Wiebe N, Russell K, et al. A meta-analysis of randomized controlled trials evaluating the efficacy of epinephrine for the treatment of acute viral bronchiolitis. Arch Pediatr Adolesc Med 2003;157(10):957-64.
21. American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics 2006;118(4): 1774-93.
22. Hartling L, Fernandes RM, Bialy L, et al. Steroids and bronchodilators for acute bronchiolitis in the first two years of life: systematic review and meta-analysis. BMJ 2011;342: d1714.
23. Skjerven HO, Hunderi JO, Brügmann-Pieper SK, et al. Racemic adrenaline and inhalation strategies in acute bronchiolitis. N Engl J Med 2013;368(24):2286-93.
24. Ralston SL, Lieberthal AS, Meissner HC, et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics 2014;134(5):e1474-502.
25. Friedman JN, Rieder MJ, Walton JM. Bronchiolitis: Recommendations for diagnosis, monitoring and management of children one to 24 months of age. Paediatr Child Health 2014;19(9):485-98.
26. Johnson DW, Adair C, Brant R, et al. Differences in admission rates of children with bronchiolitis by pediatric and general emergency departments. Pediatrics 2002; 110(4):e49.
27. Ralston S, Garber M, Narang S, et al. Decreasing unnecessary utilization in acute bronchiolitis care: results from the value in inpatient pediatrics network. J Hosp Med 2013; 8(1):25-30.
28. Garrison MM, Christakis DA, Harvey E, et al. Systemic corticosteroids in infant bronchiolitis: A meta-analysis. Pediatrics 2000;105(4):E44.
29. Patel H, Gouin S, Platt RW. Randomized, double-blind, placebo-controlled trial of oral albuterol in infants with mild-to-moderate acute viral bronchiolitis. J Pediatr 2003;142(5):509-14.
30. Gupta P, Aggarwal A, Gupta P, et al. Oral salbutamol for symptomatic relief in mild bronchiolitis a double blind randomized placebo controlled trial. Indian Pediatr 2008; 45(7):547-53.
31. Everard ML, Bara A, Kurian M, et al. Anticholinergic drugs for wheeze in children under the age of two years. Cochrane Database Syst Rev 2002;1:CD001279.
32. Walker C, Danby S, Turner S. Impact of a bronchiolitis clinical care pathway on treatment and hospital stay. Eur J Pediatr 2012;171(5):827-32.
33. Christakis DA, Cowan CA, Garrison MM, et al. Variation in inpatient diagnostic testing and management of bronchiolitis. Pediatrics 2005;115(4):878-84.
34. Russell K, Wiebe N, Saenz A, et al. Glucocorticoids for croup. Cochrane Database Syst Rev 2004;1:CD001955.
35. Plotnick LH, Ducharme FM. Combined inhaled anticholinergics and beta2-agonists for initial treatment of acute asthma in children. Cochrane Database Syst Rev 2000:4: CD000060.
36. Mittal V, Hall M, Morse R, et al. Impact of inpatient bronchiolitis clinical practice guideline implementation on testing and treatment. J Pediatr 2014;165(3):570-6.e3.
37. Parikh K, Hall M, Teach SJ. Bronchiolitis management before and after the AAP guidelines. Pediatrics 2014;133(1):e1-7.
38. Van Cleve WC, Christakis DA. Unnecessary care for bronchiolitis decreases with increasing inpatient prevalence of bronchiolitis. Pediatrics 2011;128(5):e1106-12.
39. Johnson LW, Robles J, Hudgins A, et al. Management of bronchiolitis in the emergency department: impact of evidence-based guidelines? Pediatrics 2013;131(Suppl 1): S103-9.
40. Norwood A, Mansbach JM, Clark S, et al. Prospective multicenter study of bronchiolitis: predictors of an unscheduled visit after discharge from the emergency department. Acad Emerg Med 2010;17(4):376-82.
41. Lapillonne A, Regnault A, Gournay V, et al. Impact on parents of bronchiolitis hospitalization of full-term, preterm and congenital heart disease infants. BMC Pediatr 2012;12:171.